Journal of Addiction Medicine

Skip Navigation LinksHome > March 2012 - Volume 6 - Issue 1 > Ethyl Glucuronide for Detecting Alcohol Lapses in Patients W...
Journal of Addiction Medicine:
doi: 10.1097/ADM.0b013e3182249b93
Original Research

Ethyl Glucuronide for Detecting Alcohol Lapses in Patients With an Alcohol Use Disorder

Lahmek, Pierre MD; Michel, Laurent PhD; Diviné, Catherine MD; Meunier, Nadine MD; Pham, Béatrice MD; Cassereau, Catherine MD; Aussel, Christian MD; Aubin, Henri-Jean PhD

Collapse Box


Urine ethyl glucuronide (EtG) was screened in 75 patients during a hospital-based treatment for an alcohol use disorder. During follow-up, EtG was detected in 35 (14.6%) of the 239 urine samples. Positive screens were found in 22 patients (29%), of whom nine were outpatients (39.1% of all outpatients) and 13 inpatients (25.0% of all inpatients). Of the 22 patients with positive EtG, five (22%) also gave a positive breath alcohol test and 10 (45.5%) reported recent alcohol consumption; 12 (54.5%) gave a negative breath alcohol test and declared no alcohol lapse. Ethyl glucuronide has been found useful in detecting covered lapses.

© 2012 American Society of Addiction Medicine

Follow us on Social Media!



Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.